GLF
SANA icon

Groupe la Francaise’s Sana Biotechnology SANA Stock Holding History

Groupe la Francaise’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$3.01K – 719
2025
Q3 		$3.01K Buy
+1,000
New +$3.62K ﹤0.01% 686

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Groupe la Francaise's SANA Position: Q4 2025 in Review

Groupe la Francaise sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 1,000 shares — an estimated $3.01K sold.

Groupe la Francaise first reported a position in SANA in Q3 2025 and held it in 1 quarter. The position peaked at $3.01K in Q3 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Groupe la Francaise reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 1,000 Sana Biotechnology shares in Q4 2025, an estimated $3.01K.
  • Groupe la Francaise first reported a position in Sana Biotechnology in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's Sana Biotechnology position peaked at $3.01K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.